Cargando…

Excitatory amino acids : clinical results with antagonists /

Glutamate is the major excitatory neurotransmitter in the brain and dysfunction of glutamate transmission is the likely cause of a variety of diseases including neurodegeneration following cerebral ischemia, Huntington's chorea, amyotrophic lateral sclerosis, epilepsy, spasticity, emesis, chron...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Herrling, P. L.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: San Diego : Academic Press, �1997.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_ocn162128810
003 OCoLC
005 20231117014741.0
006 m o d
007 cr cn|||||||||
008 070802s1997 caua ob 001 0 eng d
040 |a OPELS  |b eng  |e pn  |c OPELS  |d OPELS  |d OCLCQ  |d IDEBK  |d OCLCQ  |d N$T  |d YDXCP  |d OCLCE  |d E7B  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCF  |d CHVBK  |d DEBSZ  |d OCLCQ  |d UAB  |d OCLCQ  |d CASUM  |d OCLCA  |d STF  |d D6H  |d OCLCO  |d OCLCQ  |d AU@  |d OCLCA  |d S2H  |d OCLCO  |d OCLCQ  |d OCLCO  |d INARC  |d COM  |d OCLCO  |d OCLCQ  |d OCLCO 
016 7 |a 573155305  |2 DE-101 
019 |a 180765604  |a 605746798  |a 608130409  |a 742284742  |a 987773982  |a 1011199547  |a 1035656625  |a 1058040960  |a 1086559854  |a 1280893759 
020 |a 9780125468206 
020 |a 0125468202 
020 |a 9780080531342  |q (electronic bk.) 
020 |a 0080531342  |q (electronic bk.) 
035 |a (OCoLC)162128810  |z (OCoLC)180765604  |z (OCoLC)605746798  |z (OCoLC)608130409  |z (OCoLC)742284742  |z (OCoLC)987773982  |z (OCoLC)1011199547  |z (OCoLC)1035656625  |z (OCoLC)1058040960  |z (OCoLC)1086559854  |z (OCoLC)1280893759 
042 |a dlr 
050 4 |a QP364.7  |b .E93 1997 
060 4 |a 1997 C-952 
060 4 |a QV 126  |b E97 1997 
072 7 |a MJN  |2 bicssc 
072 7 |a MED  |x 057000  |2 bisacsh 
072 7 |a PSY  |x 020000  |2 bisacsh 
082 0 4 |a 612.825  |2 22 
245 0 0 |a Excitatory amino acids :  |b clinical results with antagonists /  |c edited by P.L. Herrling. 
260 |a San Diego :  |b Academic Press,  |c �1997. 
300 |a 1 online resource (xii, 156 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Glutamate is the major excitatory neurotransmitter in the brain and dysfunction of glutamate transmission is the likely cause of a variety of diseases including neurodegeneration following cerebral ischemia, Huntington's chorea, amyotrophic lateral sclerosis, epilepsy, spasticity, emesis, chronic pain, and schizophrenia. Excitatory amino acid receptor agonists and antagonists are therefore of major interest as potential drugs for central nervous system disorders. Excitatory Amino Acids is the first book entirely dedicated to the results of human testing of modulators of excitatory amino acid neurotransmitters. Features include: * Coverage of the field of excitatory amino acids from synaptic function to preclinical and clinical pharmacology * Description of the development of NMDA (Nmethyl-d-aspartate) and non-NMDA antagonists * Reports of potential drugs in early and late clinical stages of development. 
505 0 |a M. Schmutz, A. Arthur, H. Faleck, G. Karlsson, A. Kotake, L. Landwicki, L. LaRue, S. Markabi, D. Murphy, M. Powell, and D. Sauer, Selfotel. -- P. Herrling et al., D-CPPene (SDZ EAA-494) A Competitive NMDA Antagonist: Pharmacology and Results in Humans. -- J.D. Kristensen, Intrathecal Administration of a Competitive NMDA Receptor Antagonist for Pain Treatment. -- A.G. Knapp, L.I. Matthews, and E.R. Gamzu, Clinical Experience with the NMDA Ion-Channel Blocker, Aptiganel Hydrochloride (CEROSTAT). -- M.-L. Maccecchini, Development of ACPC: A Partial Agonist of the Glycine Site on the NMDA Receptor. -- Carter et al., Ifenprodil and Eliprodil: Neuroprotective NMDA Receptor Antagonists and Calcium Channel Blockers. -- D. Lodge and D.D. Schoepp, 3S, 8aR-6-[2-(1(2)H-tetrazole-5-y)ethyl] Decahydroisoquinoline-3-carboxylic Acid (LY293558) and Its Racemate (LY215490): A Selective and Competitive AMPA/Kainate Receptor Agonist. -- L. Nordholm, M. Sheardown, and T. Honore, The NBQX Story. -- E. Louvel, Riluzole in Amytrophic Lateral Sclerosis. -- G.C. Plamer and J.B. Hutchinson, Preclinical and Clinical Aspects of Remacemide Hydrochloride. 
504 |a Includes bibliographical references (pages 129-152) and index. 
588 0 |a Print version record. 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
650 0 |a Excitatory amino acids. 
650 0 |a Excitatory amino acids  |x Pathophysiology. 
650 0 |a Methyl aspartate  |x Receptors. 
650 2 |a Excitatory Amino Acids  |x antagonists & inhibitors  |0 (DNLM)D018846Q000037 
650 2 |a Excitatory Amino Acids  |x pharmacology  |0 (DNLM)D018846Q000494 
650 2 |a Excitatory Amino Acids  |0 (DNLM)D018846 
650 6 |a Acides amin�es excitateurs.  |0 (CaQQLa)201-0218584 
650 6 |a Acides amin�es excitateurs  |0 (CaQQLa)201-0218584  |x Physiopathologie.  |0 (CaQQLa)201-0379296 
650 6 |a M�ethylaspartate  |0 (CaQQLa)201-0250087  |x R�ecepteurs.  |0 (CaQQLa)201-0375415 
650 7 |a MEDICAL  |x Neuroscience.  |2 bisacsh 
650 7 |a PSYCHOLOGY  |x Neuropsychology.  |2 bisacsh 
650 7 |a Excitatory amino acids  |2 fast  |0 (OCoLC)fst00917715 
650 7 |a Excitatory amino acids  |x Pathophysiology  |2 fast  |0 (OCoLC)fst00917716 
650 7 |a Methyl aspartate  |x Receptors  |2 fast  |0 (OCoLC)fst01018742 
700 1 |a Herrling, P. L. 
776 0 8 |i Print version:  |t Excitatory amino acids.  |d San Diego : Academic Press, �1997  |z 0125468202  |z 9780125468206  |w (OCoLC)36568957 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780125468206  |z Texto completo